ADELMAN, DANIEL C.,SILVERMAN, JEFFREY A.,MASARU, HIGAKI,SATOSHI, NAKAO
申请号：
PL10177951
公开号：
PL2295056T3
申请日:
2005.03.14
申请国别(地区):
PL
年份:
2016
代理人:
摘要：
The present invention relates to a compound which is (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in treating a hematologic cancer, wherein the compound is prepared to be administered in a dose of 60 mg/m 2 - 110 mg/m 2 .
